In fact, systemic concentrations of IGFBP-3 and IGF-I were increased after application of the angiotensin-converting enzyme-inhibitor Fosinopril, and the beneficial effects of treatment in IHD were discussed in the context of the IGF-system (62). The gene discussed is IGFBP3; the disease is myocardial ischemia.